Heron Therapeutics Inc

NEW
FRA:AXD2 (USA)   Ordinary Shares
€ 0.38 -0.0022 (-0.58%) Jul 3
At Loss
P/B:
10.20
Market Cap:
€ 72.87M ($ 83.38M)
Enterprise V:
€ 158.83M ($ 181.75M)
Volume:
21.10K
Avg Vol (2M):
4.03K
Trade In:
Volume:
21.10K
At Loss
Avg Vol (2M):
4.03K

Heron Therapeutics Inc (FRA:AXD2) Dividend

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:AXD2 Dividend

Does Heron Therapeutics Inc (FRA:AXD2) pay a dividend?

Heron Therapeutics Inc (FRA:AXD2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Heron Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Heron Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.5% over the past 3 years.

What are dividend-paying alternatives to Heron Therapeutics Inc?

For dividend-paying alternatives in Heron Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.